Leverage Cognate’s Unparalleled Cell-Based cGMP manufacturing expertise combined with a broad spectrum of targeted services for effective and optimized commercialization.
International experience providing full support through out all stages of commercial development. Cognate provides the most efficient translation from concept to market.
Cell Therapy Services
Access an array of technical and specialized manufacturing and development services backed by an unsurpassed track record and proven expertise with cell-based technologies.
Outstanding real-world experience in navigating the evolving international regulatory pathways coupled with global know-how in translating cGMP manufacturing between countries.
Notable Industry News
- Caladrius, PCT and TrakCel to Drive Cell Therapy Manufacturing Excellence Read more →
- Japan Grants Safety Clearance to Pluristem’s PLX-PAD Cells for Use in Clinical Trials Read more →
- DefiniGEN licences lung stem cell technology from Cambridge University – See more at: http://www.businessweekly.co.uk/killer-50/50-insider/definigen-licences-lung-stem-cell-technology-cambridge-university#sthash.P9CyvY1Z.dpuf Read more →